DCMIC
Decheng Capital Management III (Cayman) Portfolio holdings
AUM
$300M
This Quarter Return
+13.8%
1 Year Return
+15.94%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$319M
AUM Growth
+$319M
(+29%)
Cap. Flow
+$29.7M
Cap. Flow
% of AUM
9.32%
Top 10 Holdings %
Top 10 Hldgs %
84.89%
Holding
29
New
5
Increased
1
Reduced
3
Closed
4
Top Buys
| 1 |
SLRN
ACELYRIN
SLRN
|
$32.5M |
| 2 |
Phathom Pharmaceuticals
PHAT
|
$12.2M |
| 3 |
Zentalis Pharmaceuticals
ZNTL
|
$7.76M |
Top Sells
| 1 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$16.1M |
| 2 |
BeyondSpring
BYSI
|
$5.55M |
| 3 |
AtriCure
ATRC
|
$1.92M |
| 4 |
Owlet
OWLT
|
$291K |
| 5 |
Adicet Bio
ACET
|
$181K |
Sector Composition
| 1 | Healthcare | 71.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
AtriCure
ATRC
$1.73B
| – | – |
-46,259
| Closed | -$1.92M |
|